Associate Director CVR
CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we’re building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide.
The Associate Director in Translational Research CVR is responsible for the design, execution, and oversight of translational and non-interventional biomarker studies, with a focus on understanding disease mechanisms, target validation, and biomarker discovery. This role plays a pivotal part in bridging preclinical research and clinical development by applying scientific expertise to support therapeutic area (TA) strategies,. The position includes scientific leadership, cross-functional collaboration, especially with Pre-clinical Pharmacology, Clinical Pharmacology, Data Science and Early Clinical Development functions, and strategic input into global research and development initiatives.
Main Responsibilities:
- Design, implement, and oversee translational and non-interventional biomarker studies, including protocol development in the fields of Cardiovascular & Renal including data analysis, and quality assurance.
- Contribute to biomarker strategies for toxicology and early clinical studies, by fully leveraging all elements for generation of Integrated Translational Evidence, i.e systematic literature reviews, integration of real-world data/evidence, insights gained from post-hoc studies and from prospective, non-interventional research studies (NIRS).
- Lead and support mechanism of action studies, biomarker discovery and development, and target validation using in vitro, ex vivo, and in vivo models, working closely with the internal Pharmacology Unit or external partners/vendors to access lab capabilities (e.g., academic institutions, biotech companies).
- Provide scientific and operational guidance to R&D projects across preclinical and clinical phases.
- Represent TR in TA Research core teams and RPTs; closely liaise with RTALs to support research strategies
- Represent Translational Research in global cross-functional teams, such as PSTs, NCETs and BETs, working closely with pre-clinical Pharmacology, Clinical Bioanalytics and Biomarkers, Clinical Pharmacology, Data Science and Early Clinical Development functions.
- Contribute to regulatory submissions, investigator brochures, and scientific publications.
- Supervise and mentor research scientists (e.g. from internal Pharmacology Units ), ensuring delivery of TA-aligned research packages.
- Maintain state-of-the-art knowledge through literature review and participation in scientific meetings.
- Support contract negotiations and patent filings in collaboration with legal teams.
- Ensure compliance with quality standards and contribute to the maintenance of the QM system.
- Provide input into strategic planning and due diligence processes for early-phase projects.
Qualifications and Experience Requirements:
- PhD, MD-PhD or equivalent in a relevant discipline (e.g., Biochemistry, Cell Biology, Immunology, Molecular Biology, Epidemiology), specific expertise in diseases relevant to CSL’s TA Strategies is a prerequisite.
- Minimum of 8–10 years of relevant experience in industry and/or academia, with a strong track record in translational research.
- Proven expertise in biomarker discovery, non-interventional study design, and translational biology.
- Experience in integrating clinical and scientific data to inform hypothesis generation and clinical development.
- Strong knowledge of epidemiological and statistical methods applied to translational and observational studies.
- Demonstrated leadership and people management skills in a matrixed, cross-functional environment.
- Excellent communication, analytical, and strategic thinking skills.
- Experience in regulatory documentation, scientific writing, and external collaborations.
- Ability to work effectively in multicultural and international teams.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Our Benefits
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
